Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

Despite staffing cuts at CMS, Organogenesis expects to manage through the challenges. Click here to read why I rate ORGO ...

The Federal Reserve continued its easing cycle in Q4, yet higher-than-expected inflation in December led the Fed to signal a ...

Antero Resources is a top natural gas investment. It plans to use its FCF to reduce debt and execute share buybacks. Read ...